QA: Checkpoint Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651407_2023_Checkpoint_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001651407, Checkpoint Therapeutics Inc

  xvar xval
0 AssetsCurrent 13,290,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 32,773,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,769,751
9 ResearchAndDevelopmentExpense 49,658,061
10 remainder_Expenses 0
11 remainder_Revenues 211,767
12 remainder_NetIncome -9,970,421
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 13,290,000
1 Liabilities 32,773,000
2 Expenses 58,427,812
3 Revenues 211,767
4 StockholdersEquity -19,483,000
5 NetIncome -68,186,466
6 ComprehensiveNetIncome -68,186,466
7 BaseVar 57,336,500
8 EconomicCapitalRatiobeforeLimitedLiability -4.80
9 EconomicCapitalRatio 0.222

Edgar->Model Mapping

Feature Distribution

Change over Time